Cargando…

An inflammatory-CCRK circuitry drives mTORC1-dependent metabolic and immunosuppressive reprogramming in obesity-associated hepatocellular carcinoma

Obesity increases the risk of hepatocellular carcinoma (HCC) especially in men, but the molecular mechanism remains obscure. Here, we show that an androgen receptor (AR)-driven oncogene, cell cycle-related kinase (CCRK), collaborates with obesity-induced pro-inflammatory signaling to promote non-alc...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Hanyong, Yang, Weiqin, Tian, Yuan, Zeng, Xuezhen, Zhou, Jingying, Mok, Myth T. S., Tang, Wenshu, Feng, Yu, Xu, Liangliang, Chan, Anthony W. H., Tong, Joanna H., Cheung, Yue-Sun, Lai, Paul B. S., Wang, Hector K. S., Tsang, Shun-Wa, Chow, King-Lau, Hu, Mengying, Liu, Rihe, Huang, Leaf, Yang, Bing, Yang, Pengyuan, To, Ka-Fai, Sung, Joseph J. Y., Wong, Grace L. H., Wong, Vincent W. S., Cheng, Alfred S. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283830/
https://www.ncbi.nlm.nih.gov/pubmed/30523261
http://dx.doi.org/10.1038/s41467-018-07402-8
_version_ 1783379226835025920
author Sun, Hanyong
Yang, Weiqin
Tian, Yuan
Zeng, Xuezhen
Zhou, Jingying
Mok, Myth T. S.
Tang, Wenshu
Feng, Yu
Xu, Liangliang
Chan, Anthony W. H.
Tong, Joanna H.
Cheung, Yue-Sun
Lai, Paul B. S.
Wang, Hector K. S.
Tsang, Shun-Wa
Chow, King-Lau
Hu, Mengying
Liu, Rihe
Huang, Leaf
Yang, Bing
Yang, Pengyuan
To, Ka-Fai
Sung, Joseph J. Y.
Wong, Grace L. H.
Wong, Vincent W. S.
Cheng, Alfred S. L.
author_facet Sun, Hanyong
Yang, Weiqin
Tian, Yuan
Zeng, Xuezhen
Zhou, Jingying
Mok, Myth T. S.
Tang, Wenshu
Feng, Yu
Xu, Liangliang
Chan, Anthony W. H.
Tong, Joanna H.
Cheung, Yue-Sun
Lai, Paul B. S.
Wang, Hector K. S.
Tsang, Shun-Wa
Chow, King-Lau
Hu, Mengying
Liu, Rihe
Huang, Leaf
Yang, Bing
Yang, Pengyuan
To, Ka-Fai
Sung, Joseph J. Y.
Wong, Grace L. H.
Wong, Vincent W. S.
Cheng, Alfred S. L.
author_sort Sun, Hanyong
collection PubMed
description Obesity increases the risk of hepatocellular carcinoma (HCC) especially in men, but the molecular mechanism remains obscure. Here, we show that an androgen receptor (AR)-driven oncogene, cell cycle-related kinase (CCRK), collaborates with obesity-induced pro-inflammatory signaling to promote non-alcoholic steatohepatitis (NASH)-related hepatocarcinogenesis. Lentivirus-mediated Ccrk ablation in liver of male mice fed with high-fat high-carbohydrate diet abrogates not only obesity-associated lipid accumulation, glucose intolerance and insulin resistance, but also HCC development. Mechanistically, CCRK fuels a feedforward loop by inducing STAT3-AR promoter co-occupancy and transcriptional up-regulation, which in turn activates mTORC1/4E-BP1/S6K/SREBP1 cascades via GSK3β phosphorylation. Moreover, hepatic CCRK induction in transgenic mice stimulates mTORC1-dependent G(−)csf expression to enhance polymorphonuclear myeloid-derived suppressor cell recruitment and tumorigenicity. Finally, the STAT3-AR-CCRK-mTORC1 pathway components are concordantly over-expressed in human NASH-associated HCCs. These findings unveil the dual roles of an inflammatory-CCRK circuitry in driving metabolic and immunosuppressive reprogramming through mTORC1 activation, thereby establishing a pro-tumorigenic microenvironment for HCC development.
format Online
Article
Text
id pubmed-6283830
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-62838302018-12-10 An inflammatory-CCRK circuitry drives mTORC1-dependent metabolic and immunosuppressive reprogramming in obesity-associated hepatocellular carcinoma Sun, Hanyong Yang, Weiqin Tian, Yuan Zeng, Xuezhen Zhou, Jingying Mok, Myth T. S. Tang, Wenshu Feng, Yu Xu, Liangliang Chan, Anthony W. H. Tong, Joanna H. Cheung, Yue-Sun Lai, Paul B. S. Wang, Hector K. S. Tsang, Shun-Wa Chow, King-Lau Hu, Mengying Liu, Rihe Huang, Leaf Yang, Bing Yang, Pengyuan To, Ka-Fai Sung, Joseph J. Y. Wong, Grace L. H. Wong, Vincent W. S. Cheng, Alfred S. L. Nat Commun Article Obesity increases the risk of hepatocellular carcinoma (HCC) especially in men, but the molecular mechanism remains obscure. Here, we show that an androgen receptor (AR)-driven oncogene, cell cycle-related kinase (CCRK), collaborates with obesity-induced pro-inflammatory signaling to promote non-alcoholic steatohepatitis (NASH)-related hepatocarcinogenesis. Lentivirus-mediated Ccrk ablation in liver of male mice fed with high-fat high-carbohydrate diet abrogates not only obesity-associated lipid accumulation, glucose intolerance and insulin resistance, but also HCC development. Mechanistically, CCRK fuels a feedforward loop by inducing STAT3-AR promoter co-occupancy and transcriptional up-regulation, which in turn activates mTORC1/4E-BP1/S6K/SREBP1 cascades via GSK3β phosphorylation. Moreover, hepatic CCRK induction in transgenic mice stimulates mTORC1-dependent G(−)csf expression to enhance polymorphonuclear myeloid-derived suppressor cell recruitment and tumorigenicity. Finally, the STAT3-AR-CCRK-mTORC1 pathway components are concordantly over-expressed in human NASH-associated HCCs. These findings unveil the dual roles of an inflammatory-CCRK circuitry in driving metabolic and immunosuppressive reprogramming through mTORC1 activation, thereby establishing a pro-tumorigenic microenvironment for HCC development. Nature Publishing Group UK 2018-12-06 /pmc/articles/PMC6283830/ /pubmed/30523261 http://dx.doi.org/10.1038/s41467-018-07402-8 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Sun, Hanyong
Yang, Weiqin
Tian, Yuan
Zeng, Xuezhen
Zhou, Jingying
Mok, Myth T. S.
Tang, Wenshu
Feng, Yu
Xu, Liangliang
Chan, Anthony W. H.
Tong, Joanna H.
Cheung, Yue-Sun
Lai, Paul B. S.
Wang, Hector K. S.
Tsang, Shun-Wa
Chow, King-Lau
Hu, Mengying
Liu, Rihe
Huang, Leaf
Yang, Bing
Yang, Pengyuan
To, Ka-Fai
Sung, Joseph J. Y.
Wong, Grace L. H.
Wong, Vincent W. S.
Cheng, Alfred S. L.
An inflammatory-CCRK circuitry drives mTORC1-dependent metabolic and immunosuppressive reprogramming in obesity-associated hepatocellular carcinoma
title An inflammatory-CCRK circuitry drives mTORC1-dependent metabolic and immunosuppressive reprogramming in obesity-associated hepatocellular carcinoma
title_full An inflammatory-CCRK circuitry drives mTORC1-dependent metabolic and immunosuppressive reprogramming in obesity-associated hepatocellular carcinoma
title_fullStr An inflammatory-CCRK circuitry drives mTORC1-dependent metabolic and immunosuppressive reprogramming in obesity-associated hepatocellular carcinoma
title_full_unstemmed An inflammatory-CCRK circuitry drives mTORC1-dependent metabolic and immunosuppressive reprogramming in obesity-associated hepatocellular carcinoma
title_short An inflammatory-CCRK circuitry drives mTORC1-dependent metabolic and immunosuppressive reprogramming in obesity-associated hepatocellular carcinoma
title_sort inflammatory-ccrk circuitry drives mtorc1-dependent metabolic and immunosuppressive reprogramming in obesity-associated hepatocellular carcinoma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283830/
https://www.ncbi.nlm.nih.gov/pubmed/30523261
http://dx.doi.org/10.1038/s41467-018-07402-8
work_keys_str_mv AT sunhanyong aninflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma
AT yangweiqin aninflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma
AT tianyuan aninflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma
AT zengxuezhen aninflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma
AT zhoujingying aninflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma
AT mokmythts aninflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma
AT tangwenshu aninflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma
AT fengyu aninflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma
AT xuliangliang aninflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma
AT chananthonywh aninflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma
AT tongjoannah aninflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma
AT cheungyuesun aninflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma
AT laipaulbs aninflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma
AT wanghectorks aninflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma
AT tsangshunwa aninflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma
AT chowkinglau aninflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma
AT humengying aninflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma
AT liurihe aninflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma
AT huangleaf aninflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma
AT yangbing aninflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma
AT yangpengyuan aninflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma
AT tokafai aninflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma
AT sungjosephjy aninflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma
AT wonggracelh aninflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma
AT wongvincentws aninflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma
AT chengalfredsl aninflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma
AT sunhanyong inflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma
AT yangweiqin inflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma
AT tianyuan inflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma
AT zengxuezhen inflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma
AT zhoujingying inflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma
AT mokmythts inflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma
AT tangwenshu inflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma
AT fengyu inflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma
AT xuliangliang inflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma
AT chananthonywh inflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma
AT tongjoannah inflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma
AT cheungyuesun inflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma
AT laipaulbs inflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma
AT wanghectorks inflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma
AT tsangshunwa inflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma
AT chowkinglau inflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma
AT humengying inflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma
AT liurihe inflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma
AT huangleaf inflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma
AT yangbing inflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma
AT yangpengyuan inflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma
AT tokafai inflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma
AT sungjosephjy inflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma
AT wonggracelh inflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma
AT wongvincentws inflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma
AT chengalfredsl inflammatoryccrkcircuitrydrivesmtorc1dependentmetabolicandimmunosuppressivereprogramminginobesityassociatedhepatocellularcarcinoma